What is the most recent earnings date for SNDX stock?
SYNDAX PHARMACEUTICALS INC (SNDX) last reported earnings on 2/26/2026.
SYNDAX PHARMACEUTICALS INC (SNDX) Earnings History & Surprises
NASDAQ:SNDX • US87164F1057
Current stock price
21.32 USD
-0.07 (-0.33%)
Last:
SNDX Earnings overview
Past quarterly earnings results for SYNDAX PHARMACEUTICALS INC (SNDX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.63
- Revenue Estimate
- 72.758M
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.78
- EPS Surprise
- -30.92%
- Revenue Surprise
- 5.34%
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.78 | -0.60 | -30.92% | 29.09% | 68.728M | 65.247M | 5.34% | 794.90% |
| Q3 2025 | -0.70 | -0.73 | 4.24% | 28.57% | 45.871M | 48.936M | -6.26% | 266.97% |
| Q2 2025 | -0.83 | -1.04 | 19.92% | -3.75% | 37.958M | 27.361M | 38.73% | 984.51% |
| Q1 2025 | -0.98 | -1.36 | 27.80% | -15.29% | 20.042M | 14.722M | 36.14% | - |
| Q4 2024 | -1.10 | -0.23 | -370.62% | -10.00% | 7.68M | 87.63M | -91.24% | - |
| Q3 2024 | -0.98 | -1.14 | 13.67% | -34.25% | 12.5M | 11.423M | 9.43% | - |
| Q2 2024 | -0.80 | -0.93 | 14.20% | -25.00% | 3.5M | - | - | |
| Q1 2024 | -0.85 | -1.00 | 14.84% | -44.07% | - | - | ||
| Q4 2023 | -1.00 | -1.01 | 1.39% | -61.29% | - | - | ||
| Q3 2023 | -0.73 | -0.81 | 10.03% | -25.86% | - | - | ||
| Q2 2023 | -0.64 | -0.75 | 14.31% | -3.23% | - | - | ||
| Q1 2023 | -0.59 | -0.61 | 2.90% | 6.35% | 437.141K | -100.00% | - | |
| Q4 2022 | -0.62 | -0.66 | 6.31% | -134.25% | 382.5K | -100.00% | -100.00% | |
| Q3 2022 | -0.58 | -0.65 | 10.45% | -45.00% | 765K | -100.00% | -100.00% | |
| Q2 2022 | -0.62 | -0.65 | 4.53% | -40.91% | 1.403M | -100.00% | -100.00% | |
| Q1 2022 | -0.63 | -0.65 | 2.73% | -16.67% | 2.173M | -100.00% | -100.00% | |
| Q4 2021 | 1.81 | 0.28 | 537.56% | 511.36% | 126.6M | 59.854M | 111.51% | 31,550.00% |
| Q3 2021 | -0.40 | -0.24 | -69.27% | 13.04% | 12.4M | 29.937M | -58.58% | 3,000.00% |
| Q2 2021 | -0.44 | -0.73 | 39.67% | -4.76% | 400K | 183.6K | 117.86% | - |
| Q1 2021 | -0.54 | -0.66 | 18.34% | 3.57% | 400K | 229.5K | 74.29% | - |
| Q4 2020 | -0.44 | -0.50 | 11.33% | - | 400K | 204K | 96.08% | - |
| Q3 2020 | -0.46 | -0.45 | -3.12% | - | 400K | 306K | 30.72% | - |
| Q2 2020 | -0.42 | -0.45 | 7.64% | - | 400K | 408K | -1.96% | - |
| Q1 2020 | -0.56 | -0.52 | -6.99% | - | 400K | 860.033K | -53.49% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
5.26%
Max EPS beat (4)
27.80%
Min EPS beat (4)
-30.92%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
18.48%
Max Revenue beat (4)
38.73%
Min Revenue beat (4)
-6.26%
Analysis
In the last 4 quarters, SNDX has beaten EPS estimates in 3 out of 4 releases
SNDX has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, SNDX has beaten the EPS estimates by 5.3% on average.
In the last 4 quarters, SNDX has beaten the revenue estimates by 18.5% on average.
Related analysis
SYNDAX PHARMACEUTICALS INC / SNDX Earnings FAQ
Did SNDX stock beat earnings estimates in the most recent quarter?
SYNDAX PHARMACEUTICALS INC (SNDX) missed EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does SNDX stock beat earnings estimates?
In the last 4 quarters, SYNDAX PHARMACEUTICALS INC (SNDX) has beaten EPS estimates in 3 out of 4 releases.